These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 80967)
1. The effect of nasal decongestant on nasal mucous velocity. Saketkhoo K; Yergin BM; Januszkiewicz A; Kovitz K; Sackner MA Am Rev Respir Dis; 1978 Aug; 118(2):251-4. PubMed ID: 80967 [TBL] [Abstract][Full Text] [Related]
2. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature. Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822 [TBL] [Abstract][Full Text] [Related]
3. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Suh SH; Chon KM; Min YG; Jeong CH; Hong SH Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640 [TBL] [Abstract][Full Text] [Related]
4. [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters]. Verse T; Sikora C; Rudolph P; Klöcker N Laryngorhinootologie; 2003 Nov; 82(11):782-9. PubMed ID: 14634896 [TBL] [Abstract][Full Text] [Related]
5. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Graf P; Hallén H Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089 [TBL] [Abstract][Full Text] [Related]
6. [In vitro studies of the effect of vasoconstrictor nose drops on ciliary epithelium of human nasal mucosa]. Hofmann T; Wolf G; Koidl B Laryngorhinootologie; 1995 Sep; 74(9):564-7. PubMed ID: 7495440 [TBL] [Abstract][Full Text] [Related]
7. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Graf P Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860 [TBL] [Abstract][Full Text] [Related]
8. The effect of topical xylometazoline on the mucosal temperature of the nasal septum. Lindemann J; Leiacker R; Rettinger G; Keck T Am J Rhinol; 2002; 16(4):229-34. PubMed ID: 12222949 [TBL] [Abstract][Full Text] [Related]
9. Effects of topical drops and sprays on mucociliary transport time and nasal air flow. Bercin S; Ural A; Kutluhan A Acta Otolaryngol; 2009 Nov; 129(11):1257-61. PubMed ID: 19863321 [TBL] [Abstract][Full Text] [Related]
10. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit. Bende M; Arfors KE; Intaglietta M ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443 [TBL] [Abstract][Full Text] [Related]
11. Paranasal sinusitis after long-term use of topical nasal decongestants. Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749 [TBL] [Abstract][Full Text] [Related]
12. [Ciliary epithelium and topical decongestants: how to minimize the undesirable events?]. Laberko EL; Zlobina NV; Radtsig EY; Bogomil'sky MR Vestn Otorinolaringol; 2014; (5):76-9. PubMed ID: 25588494 [TBL] [Abstract][Full Text] [Related]
13. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo. Storaas T; Andersson M; Persson CG; Steinsvåg SK; Marko-Varga G; Greiff L Laryngoscope; 2000 Sep; 110(9):1543-7. PubMed ID: 10983958 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo. Cogo A; Chieffo A; Farinatti M; Ciaccia A Arzneimittelforschung; 1996 Apr; 46(4):385-8. PubMed ID: 8740084 [TBL] [Abstract][Full Text] [Related]
15. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant]. Teng Y; Zhang X; Xu G; Cai Q; Xu J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111 [TBL] [Abstract][Full Text] [Related]
16. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Hallén H; Graf P Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242 [TBL] [Abstract][Full Text] [Related]
17. The effect of decongestive nosedrops on human respiratory mucosa in vitro. Berg OH; Lie K; Steinsvåg SK Laryngoscope; 1994 Sep; 104(9):1153-8. PubMed ID: 7520965 [TBL] [Abstract][Full Text] [Related]
18. Nasal airflow asymmetry and the effects of a topical nasal decongestant. Williams RG; Eccles R Rhinology; 1992 Dec; 30(4):277-82. PubMed ID: 1281924 [TBL] [Abstract][Full Text] [Related]
19. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa. Browning S; Housley D; Richards R; Eccles R Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826 [TBL] [Abstract][Full Text] [Related]
20. The inhibition of granulocyte phagocytosis by various components of nasal drops. Håkansson B; Linder C; Ohlsson K; Tegner H; Toremalm NG Pharmacol Toxicol; 1989 Aug; 65(2):89-91. PubMed ID: 2478992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]